The Associates Course expands the knowledge base of participants to improve patient outcomes in behavioral, nutritional, and pharmacologic interventions in chronic liver disease. Speakers explore topics including: (1) novel treatment models of chronic hepatitis C and MASLD/MASH; (2) pharmacist driven management of chronic liver disease; (3) resource-limited management of chronic liver disease; and (4) palliative approaches to management of patients with chronic liver disease.

Join us for a poster highlight of the top abstracts from the ACLF SIG. 
 

Artifical intelligence (AI) affects multiple areas of our lives as clinicians, researchers, and patients. This session focuses on the rapidly evolving role of AI in liver disease care. Experts address (1) the potential role of AI in predicting disease progression, treatment response, and long-term outcomes; (2) limitations and challenges in the use of AI in the liver care setting; and (3) how AI is influencing communication between clinicians and their patients.

Join the Liver Fellows Network for a live podcast recording of Liver Talks, the official podcast of the Liver Fellow Network. In this special episode, “Tips for TIPS”, we will explore a complex case of portal hypertension through an engaging, case-based discussion with expert hepatologists Dr. Brett E. Fortune and Dr. David E. Kaplan.
 

The Patient Engagement in Drug Development: Leading Through Example (PEDDLE) Working Group, an initiative of the Liver Forum, is developing tools and best practices to make patient engagement a consistent part of MASH drug development. This session will introduce the Patient Engagement Toolkit, a framework designed to guide how patient perspectives are integrated across all stages of clinical research. Speakers will discuss how PEDDLE’s work connects with FDA guidance on non-invasive tests (NITs) and current discussions around diversity and trial representation. Co-chairs from a patient organization and industry will discuss how structured patient engagement can enhance recruitment, retention, data relevance, and trust in developing effective MASH therapies.

Zoom: https://us02web.zoom.us/webinar/register/WN_FHLtwb2VSc6geLfq21aOuA

Come discuss the upcoming AASLD guideline on treatment of chronic hepatitis B with the co-chairs of the guideline. What has changed?
 
9:45-9:55 AM- Presentation
9:55-10:15 AM- Audience Q&A and Discussion
 
 

As the majority of transplant hepatology trainees are women, it is essential to focus on recruiting and retaining this talented group to ensure a thriving hepatology division. Evidence highlights that workplace bias, family-unfriendly work environments, and gender pay inequities are significant challenges that need to be addressed. This community conversation begins with a brief expert review of the evidence behind workplace gender inequities and exploration of successful structural solutions. A diverse panel—including division chiefs with successful recruitment records, a female fellow trainee, an early-career female physician, and a mid-career female physician—then share their experiences with fellowship applications and job searches.

This community conversation is designed to inspire and guide hepatology associates as they transition from competency to expert practice. Through a dynamic panel discussion, participants explore strategies to elevate their careers by engaging with professional organizations, expanding clinical and leadership skills, and mastering the art of self-advocacy. Panelists share insights on leveraging current skill sets, fostering peer collaboration and mentorship, and creating pathways for career growth in hepatology. 

This community conversation aims to empower hepatology practitioners to optimize their use of the electronic health record (EHR) for improved clinical workflows and research capabilities. Key topics include: live demonstrations of hepatology-specific EHR workflows; practical tips and best practices for Epic and Oracle Health EHRs; and an introduction to Epic's SlicerDicer tool for clinical research. An interactive hands-on workshop follows the presentations, allowing participants to "choose their own adventure" at designated stations where they can explore EHR tools, receive guidance from presenters, and interact with Epic and Oracle Health experts. By the end of the session, participants will have actionable strategies to implement and tailor EHR tools locally and across health systems.

Progressive familial intrahepatic cholestasis (PFIC) is a group of disorders associated with the accumulation of toxic bile acids and progressive liver injury. In this presentation, Dr Gish will review the signs / symptoms of PFIC, examine the role of genetic testing in diagnosis, and discuss considerations for treatment of adults with PFIC.

Industry Supporter: Mirum Pharmaceuticals